Follow
Jitendra Kanodia
Jitendra Kanodia
Xencor, Theravance Biopharma, Genentech Roche, Merrimack Pharmaceuticals, Princeton University
Verified email at theravance.com
Title
Cited by
Cited by
Year
A microfluidic array for large-scale ordering and orientation of embryos
K Chung, Y Kim, JS Kanodia, E Gong, SY Shvartsman, H Lu
Nature methods 8 (2), 171-176, 2011
1792011
Dynamics of the Dorsal morphogen gradient
JS Kanodia, R Rikhy, Y Kim, VK Lund, R DeLotto, J Lippincott-Schwartz, ...
Proceedings of the National Academy of Sciences 106 (51), 21707-21712, 2009
1292009
Non-negative matrix factorization for detection and diagnosis of plantwide oscillations
AK Tangirala, J Kanodia, SL Shah
Industrial & engineering chemistry research 46 (3), 801-817, 2007
702007
Pattern formation by graded and uniform signals in the early Drosophila embryo
JS Kanodia, HL Liang, Y Kim, B Lim, M Zhan, H Lu, CA Rushlow, ...
Biophysical Journal 102 (3), 427-433, 2012
592012
Feedback control of the EGFR signaling gradient: superposition of domain-splitting events in Drosophila oogenesis
JJ Zartman, JS Kanodia, LS Cheung, SY Shvartsman
Development 136 (17), 2903-2911, 2009
532009
Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain
K Gadkar, DB Yadav, JY Zuchero, JA Couch, J Kanodia, MK Kenrick, ...
European Journal of Pharmaceutics and Biopharmaceutics 101, 53-61, 2016
482016
Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles
J Kanodia, D Chai, J Vollmer, J Kim, A Raue, G Finn, B Schoeberl
Cell Communication and Signaling 12, 1-18, 2014
432014
Prospective design of anti‐transferrin receptor bispecific antibodies for optimal delivery into the human brain
JS Kanodia, K Gadkar, D Bumbaca, Y Zhang, RK Tong, W Luk, K Hoyte, ...
CPT: pharmacometrics & systems pharmacology 5 (5), 283-291, 2016
392016
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
I Tom, VC Pham, KJ Katschke Jr, W Li, WC Liang, J Gutierrez, A Ah Young, ...
Proceedings of the National Academy of Sciences 117 (18), 9952-9963, 2020
372020
A computational statistics approach for estimating the spatial range of morphogen gradients
JS Kanodia, Y Kim, R Tomer, Z Khan, K Chung, JD Storey, H Lu, PJ Keller, ...
Development 138 (22), 4867-4874, 2011
352011
Expression patterns of cadherin genes in Drosophila oogenesis
JJ Zartman, JS Kanodia, N Yakoby, X Schafer, C Watson, K Schlichting, ...
Gene Expression Patterns 9 (1), 31-36, 2009
272009
A compartmental model for the bicoid gradient
ME Kavousanakis, JS Kanodia, Y Kim, IG Kevrekidis, SY Shvartsman
Developmental biology 345 (1), 12-17, 2010
242010
ICH M9 guideline in development on biopharmaceutics classification system-based biowaivers: an industrial perspective from the IQ consortium
P Bransford, J Cook, M Gupta, S Haertter, H He, R Ju, J Kanodia, ...
Molecular Pharmaceutics 17 (2), 361-372, 2019
232019
Evolution of BMP signaling in Drosophila oogenesis: a receptor-based mechanism
MG Niepielko, K Ip, JS Kanodia, DS Lun, N Yakoby
Biophysical Journal 102 (8), 1722-1730, 2012
202012
A phase 1 study of plamotamab, an anti-CD20 x anti-CD3 bispecific antibody, in patients with relapsed/refractory non-Hodgkin's lymphoma: recommended dose safety/efficacy update …
K Patel, PA Riedell, H Tilly, S Ahmed, JM Michot, H Ghesquieres, ...
Blood 140 (Supplement 1), 9470-9472, 2022
142022
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
H Kaufmann, R Vickery, W Wang, J Kanodia, CA Shibao, ...
Clinical Autonomic Research 31, 699-711, 2021
142021
Transforming translation through quantitative pharmacology for high‐impact decision making in drug discovery and development
N Gupta, D Bottino, USH Simonsson, CJ Musante, T Bueters, TR Rieger, ...
Clinical Pharmacology & Therapeutics 107 (6), 1285-1289, 2020
92020
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension
A Lo, L Norcliffe-Kaufmann, R Vickery, D Bourdet, J Kanodia
Clinical Autonomic Research 31, 395-403, 2021
72021
Time to rethink the current paradigm for assessing kidney function in drug development and beyond
A Sharma, V Sahasrabudhe, L Musib, S Zhang, I Younis, J Kanodia
Clinical Pharmacology & Therapeutics 112 (5), 946-958, 2022
62022
Pharmacokinetics of ampreloxetine, a norepinephrine reuptake inhibitor, in healthy subjects and adults with attention-deficit/hyperactive disorder or fibromyalgia pain
J Kanodia, A Lo, RM Baldwin, RA Graham, DL Bourdet
Clinical Pharmacokinetics 60, 121-131, 2021
32021
The system can't perform the operation now. Try again later.
Articles 1–20